M. Kobari et al., EFFECTS OF SUMATRIPTAN ON THE CEREBRAL INTRAPARENCHYMAL MICROCIRCULATION IN THE CAT, British Journal of Pharmacology, 110(4), 1993, pp. 1445-1448
1 Sumatriptan, a 5-hydroxytryptamine (5-HT)1-like receptor agonist, is
effective against the headache of migraine. The effects of sumatripta
n injected via the carotid artery on the cerebral microcirculation wer
e studied in 10 anaesthetized cats. 2 The local cerebral blood volume
(CBV), mean transit time of blood (MTT) and cerebral blood flow (CBF)
in the parieto-temporal cortex were measured by a photoelectric method
. CBV represents the cumulative dimensions of the cerebral microvessel
s. 3 Sumatriptan at 5 and 50 mug kg-1 had no significant effects on th
e CBV, MTT, CBF, and mean arterial blood pressure (MABP); 500 mug kg-1
of sumatriptan reduced the CBV, prolonged the MTT, and decreased the
CBF (approximately - 20%) without affecting the MABP. Sumatriptan, 5 m
g kg-1, elicited transient reductions in CBV and CBF, which were attri
butable to the rapid and marked falls of MABP seen with this dose. 4 T
hus, while a high dose of sumatriptan (500 mug kg-1) exhibits direct v
asoconstrictor actions on the cerebral vessels, low doses of sumatript
an, within the therapeutic range, elicit no vasoconstriction. The data
do not support a vasoconstrictor action of sumatriptan playing a prim
ary role in reversing the headache of migraine.